Table 1.
Patient demographic data and characteristics
| Patient characteristics | Valuesa |
|---|---|
| Age (years) | |
| Mean | 38 ± 10 |
| Minimum–maximum | 24–59 |
| Age 20–40.9 years | 19 (63.3%) |
| Age 41–60 years | 11 (36.7%) |
| Age hair loss first noticed (years) | 24.8 ± 8.7 |
| Duration of hair loss (years) | 12.9 ± 11 |
| Family members experiencing AGA | 28 (93.3%) |
| Previous treatment | |
| Finasteride | 2 (20.03%) |
| Topical 5% minoxidil | 5 (16.7%) |
| Topical herbal extracts | 10 (33.3%) |
| Current smokers | 4 (13.3%) |
| Former smokers | 4 (13.3%) |
| Alcohol consumers | 20 (66.7%) |
| Underlying diseases | |
| Diabetes | 3 (10%) |
| Dyslipidemia | 7 (23.3%) |
| Hypertension | 3 (10%) |
| Metabolic syndrome | 4 (13.3%) |
| Baseline Norwood–Hamilton classification | Total patient cohort (n = 30) | Patient cohort aged < 41 years (n = 19) | Patient cohort aged ≥ 41 years (n = 11) |
|---|---|---|---|
| III vertex | 8 (26.7%) | 8 (42.1%) | 0 (0%) |
| IV | 12 (40.0%) | 4 (21.1%) | 8 (72.7%) |
| V | 10 (33.3%) | 7 (36.8%) | 3(27.3%) |
Values in table are presented as the mean ± standard deviation (SD) or as a number with the percentage in parenthesis
AGA Androgenetic alopecia
aTotal number of patients (n) = 30